Murine models of B-cell lymphomas: promising tools for designing cancer therapies
about
Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft modelsHighly efficient, in-vivo Fas-mediated apoptosis of B-cell lymphoma by hexameric CTLA4-FasL.Non-invasive bioluminescence imaging to monitor the immunological control of a plasmablastic lymphoma-like B cell neoplasia after hematopoietic cell transplantation.Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination.Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation.Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironmentBioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models.A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario.Mouse models of primary central nervous system lymphomas: tools for basing funding and therapeutic strategies.Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations.Overview of the Use of Murine Models in Leukemia and Lymphoma Research.Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.A novel orally available inhibitor of focal adhesion signaling increases survival in a xenograft model of diffuse large B-cell lymphoma with central nervous system involvement.NKT Cell Responses to B Cell Lymphoma.Mesenchymal stromal cells promote B-cell lymphoma in lacrimal glands by inducing immunosuppressive microenvironment.A simple, clinically relevant therapeutic vaccine shows long-term protection in an aggressive, delayed-treatment B lymphoma model.Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice.
P2860
Q27003955-767F0DD0-8596-4EEA-9B81-AF586B5C5DBFQ27311386-9E81827D-8CBA-4698-BB02-D181212657A7Q34306584-76040BE2-1B9C-40E8-8664-F77595830338Q35069537-4D605201-1066-408C-BE05-49409F4C46ACQ35693324-8B7D528A-4B49-464C-B113-10E0148D9C1AQ35850333-730892F9-8419-48BC-9F1F-F71A1E6BA94FQ35931598-4B1DA943-297E-41E8-9959-24E60EEDD097Q36758769-76CFF3CA-C332-49EA-85A7-155FFD8F6C00Q37194276-1A1CB4DA-14B3-4B37-A609-680A046B850AQ37428422-A504B9DB-B37A-403E-AFE4-F9000774A74AQ38258618-C7FADE80-1409-4124-9539-3F26075AB15AQ38660463-5EE617B3-6BB5-4778-91FC-58E16D798583Q38749909-655E0A91-D578-4181-8B83-D31D48F5149DQ38795442-5D62228B-4BBF-4D21-9F47-810308FC408BQ39146340-D36BE80C-953F-4DFB-9AD2-61DCE6F86F11Q40894586-339BBB21-52F9-412A-BFAF-44239E0671BFQ42371629-1426C179-5A91-4C01-82D3-EA94BC15F4AEQ47357871-2500CD76-0D98-4382-818F-C34F111FFD4FQ49395392-5BF12B44-20E4-4D4A-9834-75BFA1D1A1A9
P2860
Murine models of B-cell lymphomas: promising tools for designing cancer therapies
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Murine models of B-cell lymphomas: promising tools for designing cancer therapies
@ast
Murine models of B-cell lymphomas: promising tools for designing cancer therapies
@en
type
label
Murine models of B-cell lymphomas: promising tools for designing cancer therapies
@ast
Murine models of B-cell lymphomas: promising tools for designing cancer therapies
@en
prefLabel
Murine models of B-cell lymphomas: promising tools for designing cancer therapies
@ast
Murine models of B-cell lymphomas: promising tools for designing cancer therapies
@en
P2093
P2860
P4510
P50
P356
P1476
Murine models of B-cell lymphomas: promising tools for designing cancer therapies
@en
P2093
Sabrina Donnou
Valérie Touitou
Zsuzsanna Fabry
P2860
P304
P356
10.1155/2012/701704
P577
2012-02-12T00:00:00Z